Immediate Impact
5 from Science/Nature 72 standout
Citing Papers
Efficacy and safety of the muscarinic receptor agonist KarXT (xanomeline–trospium) in schizophrenia (EMERGENT-2) in the USA: results from a randomised, double-blind, placebo-controlled, flexible-dose phase 3 trial
2023 Standout
Muscarinic Cholinergic Receptor Agonist and Peripheral Antagonist for Schizophrenia
2021 Standout
Works of John T. Kenny being referenced
Improvement in cognitive functions and psychiatric symptoms in treatment-refractory schizophrenic patients receiving clozapine
1993
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| John T. Kenny | 559 | 406 | 60 | 165 | 26 | 1.1k | |
| Ingrid Aasen | 488 | 336 | 30 | 212 | 22 | 978 | |
| Margret S.H. Harris | 546 | 401 | 15 | 95 | 20 | 909 | |
| Verity C. Leeson | 795 | 564 | 23 | 165 | 44 | 1.3k | |
| Adham Mancini‐Marïe | 464 | 349 | 25 | 97 | 41 | 881 | |
| Douglas S. Lehrer | 668 | 330 | 41 | 160 | 24 | 1.3k | |
| Arielle D. Stanford | 619 | 357 | 28 | 172 | 40 | 1.2k | |
| R.C. Gur | 541 | 546 | 23 | 93 | 17 | 1.1k | |
| Gary Brucato | 581 | 339 | 33 | 197 | 52 | 1.1k | |
| Henning Witthaus | 513 | 618 | 75 | 183 | 16 | 1.1k | |
| Brian Kirkpatrick | 549 | 244 | 62 | 95 | 11 | 893 |
All Works
Loading papers...